Therapy News and Research

RSS

WHO calls upon countries to be alert to antimicrobial resistance

Antimicrobial resistance (AMR) - the ability of micro-organisms to find ways to evade the action of the drugs used to cure the infections they cause - is increasingly recognised as a global public health issue which could hamper the control of many infectious diseases. Some bacteria have developed mechanisms which render them resistant to many of the antibiotics normally used for their treatment (multi-drug resistant bacteria), so pose particular difficulties, as there may be few or no alternative options for therapy.

21 Aug 2010

Low testosterone levels to blame for low libido, fatigue and weight gain

While most frequently associated with women's health, age-related hormone changes, often dubbed menopause, can occur in men as well, causing symptoms of fatigue, mood swings, decreased desire for sex, hair loss, lack of concentration and weight gain. Experts estimate that more than 5 million men are affected, yet worry the number may be considerably higher since symptoms are frequently ignored.

21 Aug 2010

Impax confirms initiation of challenge of patents listed by MSP Singapore for VYTORIN

Impax Laboratories, Inc. today confirms that it has initiated a challenge of patents listed by MSP Singapore Co. LLC in connection with VYTORIN® (ezetimibe/simvastatin), 10 mg/80 mg.

21 Aug 2010

Study finds genetic change in chromosome 4 causes FSHD

The Muscular Dystrophy Association today heralds a landmark muscular dystrophy advance by an international study team of scientists and physicians from the Netherlands, United States, France and Spain. Led by MDA-grantee Silvère van der Maarel, Ph.D., at Leiden University Medical Center in the Netherlands, the collaborative study of more than 2,300 people found that two distinct genetic changes on chromosome 4 must be present to cause facioscapulohumeral muscular dystrophy (FSHD).

21 Aug 2010

Combination of 2 FDA approved drugs eliminate HIV infection

Researchers at the University of Minnesota Academic Health Center have identified two drugs that, when combined, may serve as an effective treatment for HIV.

21 Aug 2010

ETC Biomedical Systems receives FDA 510-k clearance for computer hyperbaric oxygen control system

Environmental Tectonics Corporation's Biomedical Systems, a worldwide leader in the development, manufacture of computerized monoplace hyperbaric chambers, today confirmed that it has received FDA 510-k clearance for O.S.C.A.R. ™. O.S.C.A.R. ™ is an acronym for "Operating System for Control And Recording." This computerized system is configured as a stand–alone unit that will operate, control and record whole-body hyperbaric oxygen therapy treatments.

21 Aug 2010

Protalex initiates dosing in multicenter PRTX-100 Phase 1b clinical study in RA

Protalex, Inc., a clinical stage biopharmaceutical company engaged in developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, today announced the dosing of the first patient in a multicenter Phase 1b clinical study of PRTX-100 in adult patients with active Rheumatoid Arthritis (RA). The study is being conducted in South Africa.

20 Aug 2010

Tips for management of COPD

What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million Americans are currently diagnosed with COPD and an additional 12 million may not realize their shortness of breath and coughing are in fact symptoms of this debilitating condition.

20 Aug 2010

Stent implanted in artery inside skull of 14-year-old boy to prevent stroke

University at Buffalo neurosurgeon Elad Levy, MD, implanted a stent in an artery inside the skull of a 14-year-old boy to prevent a stroke, a procedure thought to be the first conducted in an adolescent.

20 Aug 2010

NIAID's renewed 'Centers for Countermeasures Against Radiation' program to support research at 7 institutions

A major research effort to develop medical products to diagnose, prevent and treat the short- and long-term consequences of radiation exposure after a radiological or nuclear terrorist attack has been renewed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

20 Aug 2010

NSF issues award to develop techniques for analyzing children's behavior

A team led by the Georgia Institute of Technology has received a $10 million "Expeditions in Computing" award from the National Science Foundation (NSF) to develop novel computing techniques for measuring and analyzing the behavior of children.

20 Aug 2010

Tasigna receives approval for chronic myeloid leukemia in Canada

Tasigna (nilotinib) capsules have been approved with conditions in Canada as a new therapy for patients with CML, in the chronic phase (first phase) of the disease. Patients must be resistant to or intolerant of at least one prior therapy, including (Pr)Gleevec (imatinib mesylate), an established standard of care.

20 Aug 2010

Study demonstrates association between yoga postures, increased GABA levels and decreased anxiety

Researchers from Boston University School of Medicine (BUSM) have found that yoga may be superior to other forms of exercise in its positive effect on mood and anxiety. The findings, which currently appear on-line at Journal of Alternative and Complementary Medicine, is the first to demonstrate an association between yoga postures, increased GABA levels and decreased anxiety.

20 Aug 2010

Neuroscientist conducts free webinar to highlight children’s vision problems

The public is invited to a free web interview with Dr. Susan Barry, neuroscientist, professor and author of Fixing My Gaze. Dr. Barry, recently interviewed by Terry Gross on NPR's Fresh Air program, is famous for gaining 3D vision as an adult and sharing her experiences in her book, which was just released in paperback.

20 Aug 2010

Cerulean Pharma to assemble scientific experts at ACS National Meeting symposium

Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced it will assemble a group of leading scientific experts at the American Chemical Society's ("ACS") 240th National Meeting & Exposition for a three-day thought leadership summit on the advancement of nanotechnology in the pharmaceutical and diagnostic industries.

20 Aug 2010

ISCO to formalize eye care based stem cell therapeutic programs into Cytovis business unit

International Stem Cell Corporation, today announced that its stem cell therapeutic programs focused on protective, transparent corneas (CytoCor™) in the front of the eye and the light-sensitive retinal tissue (CytoRet™) in the back of the eye will be formalized into a new business unit, Cytovis™.

20 Aug 2010

Trial shows positive results for radioembolisation technique for colorectal cancer liver metastases treatment

Using the innovative technique of radioembolisation to treat patients with inoperable colorectal cancer liver metastases who have failed all standard-of-care chemotherapy options can more than double the time until their disease progresses, according to the final results of a Phase III randomised controlled trial published in the prestigious Journal of Clinical Oncology.

20 Aug 2010

UCI study is first to show reversal of long-term hind-limb paralysis

A UC Irvine study is the first to demonstrate that human neural stem cells can restore mobility in cases of chronic spinal cord injury, suggesting the prospect of treating a much broader population of patients.

20 Aug 2010

Immunosuppressive therapy benefits necrotizing myopathy patients with novel autoantibody specificity

Researchers at Johns Hopkins University School of Medicine have identified a subgroup of patients with necrotizing myopathy who have a novel autoantibody specificity that makes them potential candidates for immunosuppressive therapy. The complete study is published in the September issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.

20 Aug 2010

SIR-Spheres safe, effective for patients with colorectal cancer liver metastases who have failed chemotherapy

Radioactive yttrium-90 labelled resin microspheres (SIR-Spheres; Sirtex Medical, Sydney, Australia) appear to be a safe and effective treatment for patients with colorectal cancer liver metastases who have failed available chemotherapy options, according to the final results of a prospective clinical multi-centre phase II trial conducted by the Italian Society of Locoregional Therapies in Oncology (SITILO) and published in the British Journal of Cancer.

20 Aug 2010

Therapy News and Research

WHO calls upon countries to be alert to antimicrobial resistance

Low testosterone levels to blame for low libido, fatigue and weight gain

Impax confirms initiation of challenge of patents listed by MSP Singapore for VYTORIN

Study finds genetic change in chromosome 4 causes FSHD

Combination of 2 FDA approved drugs eliminate HIV infection

ETC Biomedical Systems receives FDA 510-k clearance for computer hyperbaric oxygen control system

Protalex initiates dosing in multicenter PRTX-100 Phase 1b clinical study in RA

Tips for management of COPD

Stent implanted in artery inside skull of 14-year-old boy to prevent stroke

NIAID's renewed 'Centers for Countermeasures Against Radiation' program to support research at 7 institutions

NSF issues award to develop techniques for analyzing children's behavior

Tasigna receives approval for chronic myeloid leukemia in Canada

Study demonstrates association between yoga postures, increased GABA levels and decreased anxiety

Neuroscientist conducts free webinar to highlight children’s vision problems

Cerulean Pharma to assemble scientific experts at ACS National Meeting symposium

ISCO to formalize eye care based stem cell therapeutic programs into Cytovis business unit

Trial shows positive results for radioembolisation technique for colorectal cancer liver metastases treatment

UCI study is first to show reversal of long-term hind-limb paralysis

Immunosuppressive therapy benefits necrotizing myopathy patients with novel autoantibody specificity

SIR-Spheres safe, effective for patients with colorectal cancer liver metastases who have failed chemotherapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News